Market Entry

OCS supports oncology companies from anywhere in the world to enter the markets of the UK/EU, USA, Middle East, and or South Africa. The core competitive advantage of OCS over other market entry companies is that OCS has deep market access, so it can obtain the data and open doors needed for the client company to make decisions and progress. The team philosophy is to be direct and honest and, where appropriate, to advise the client company to stop the process if the data show that the company cannot compete in the market.

The OCS team supports the oncology company from researching on if to enter a market or not, right through to setting up in the new market and selling products.

For Chinese Companies wishing to expand out of China, the OCS team is joined by Professor Toni Vidal-Puig MD PhD FRCP FMedSci MBA. Professor at the University of Cambridge. Research Scientist at Cambridge University Nanjing Centre of Technology and Innovation (CUNJC), Nanjing.